Nippon India Nifty Pharma ETF - Growth Plan vs Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment
NAV, returns and costs — not a recommendation.
 Nippon India Nifty Pharma ETF - Growth Plan |  Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment | |
|---|---|---|
| NAV | ₹27.1122 | ₹10.7072 |
| NAV date | 2026-08-18 | 2026-08-19 |
| 1 year | +19.49% | +8.37% |
| 3 year (p.a.) | +20.35% | +6.15% |
| 5 year (p.a.) | +14.55% | +6.15% |
| Expense ratio | 0.18% | 2.08% |
| Fund size | ₹1,622.31 Cr | ₹544.17 Cr |
| Risk | Very high | — |
| Category | Etfs | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.